دورية أكاديمية
Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
العنوان: | Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. |
---|---|
المؤلفون: | Bellamkonda N; Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA., Kull A; Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA., Monroe MM; Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, USA. |
المصدر: | Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2024 Jun 21. Date of Electronic Publication: 2024 Jun 21. |
Publication Model: | Ahead of Print |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley Country of Publication: England NLM ID: 8508176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6817 (Electronic) Linking ISSN: 01945998 NLM ISO Abbreviation: Otolaryngol Head Neck Surg Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2023- : [Oxford] : Wiley Original Publication: [Rochester, Minn.] : The Academy, [c1981- |
مستخلص: | Objective: The objective of this study was to describe risk factors and recurrence patterns that can guide the creation of evidence-based surveillance guidelines for advanced cutaneous squamous cell carcinoma of the head and neck. Study Design: This was a single-institution retrospective case series. Setting: High-volume academic head and neck surgical oncology practice. Methods: Patients who underwent surgery for cutaneous squamous cell carcinoma of the head and neck staged Brigham and Women's Hospital T2b and T3 from 2003 to 2023 were reviewed. Patient demographics, clinicopathologic history, cancer data, treatment, and outcomes were abstracted. Disease-free survival and risk factors for recurrence were described. Results: A total of 183 patients were included. Fifty-six (30.6%) experienced recurrence. This included local recurrence in 21 (11.5%), regional in 21 (13.3%), and distant in 11 (6%). The majority of regional and distant recurrences occurred within 1 year of surgery. Conclusion: The majority of disease recurrence occurs in the first 1 to 2 years following surgical excision of advanced-stage cutaneous squamous cell carcinoma of the head and neck. Close surveillance and frequent imaging within those years are critical to catch subclinical and distant diseases. (© 2024 The Authors. Otolaryngology–Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology–Head and Neck Surgery Foundation.) |
References: | Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012. JAMA Dermatol. 2015;151(10):1081‐1086. doi:10.1001/jamadermatol.2015.1187. Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78(2):237‐247. doi:10.1016/j.jaad.2017.08.059. Kosmadaki MG. The demographics of aging in the United States: implications for dermatology. Arch Dermatol. 2002;138(11):1427‐1428. doi:10.1001/archderm.138.11.1427-a. Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma. Mayo Clin Proc. 2017;92(6):890‐898. doi:10.1016/j.mayocp.2017.02.015. Harpaz R, Dahl RM, Dooling KL. Prevalence of immunosuppression among US adults, 2013. JAMA. 2016;316(23):2547. doi:10.1001/jama.2016.16477. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348(17):1681‐1691. doi:10.1056/NEJMra022137. National Comprehensive Cancer Network. NCCN Guidelines Squamous Cell Skin Cancer Version 1.2023. National Comprehensive Cancer Network; 2023. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005;53(2):320‐328. doi:10.1016/j.jaad.2005.03.043. Nguyen KD, Han J, Li T, Qureshi AA. Invasive cutaneous squamous cell carcinoma incidence in US health care workers. Arch Dermatol Res. 2014;306(6):555‐560. doi:10.1007/s00403-014-1469-3. Ruiz ES, Karia PS, Morgan FC, Schmults CD. The positive impact of radiologic imaging on high‐stage cutaneous squamous cell carcinoma management. J Am Acad Dermatol. 2017;76(2):217‐225. doi:10.1016/j.jaad.2016.08.051. Harris BN, Bayoumi A, Rao S, Moore MG, Farwell DG, Bewley AF. Factors associated with recurrence and regional adenopathy for head and neck cutaneous squamous cell carcinoma. Otolaryngol Head Neck Surg. 2017;156(5):863‐869. doi:10.1177/0194599817697053. Tschetter AJ, Campoli MR, Zitelli JA, Brodland DG. Long‐term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: a 5‐year, multicenter, prospective cohort study. J Am Acad Dermatol. 2020;82(1):139‐148. doi:10.1016/j.jaad.2019.06.1303. Soleymani T, Brodland DG, Arzeno J, Sharon DJ, Zitelli JA. Clinical outcomes of high‐risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: an analysis of local recurrence, regional nodal metastases, progression‐free survival, and disease‐specific death. J Am Acad Dermatol. 2023;88(1):109‐117. doi:10.1016/j.jaad.2022.06.1169. Maher JM, Schmults CD, Murad F, Karia PS, Benson CB, Ruiz ES. Detection of subclinical disease with baseline and surveillance imaging in high‐risk cutaneous squamous cell carcinomas. J Am Acad Dermatol. 2020;82(4):920‐926. doi:10.1016/j.jaad.2019.10.067. |
فهرسة مساهمة: | Keywords: cutaneous squamous cell carcinoma; nonmelanoma skin cancer; prognosis; squamous cell carcinoma imaging; surveillance |
تواريخ الأحداث: | Date Created: 20240720 Latest Revision: 20240720 |
رمز التحديث: | 20240721 |
DOI: | 10.1002/ohn.851 |
PMID: | 39031592 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1097-6817 |
---|---|
DOI: | 10.1002/ohn.851 |